Abacavir sulfate

CAS No. 188062-50-2

Abacavir sulfate ( Abacavir sulfate; Abacavir sulfate salt )

Catalog No. M12916 CAS No. 188062-50-2

A nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 35 In Stock
25MG 58 In Stock
50MG 88 In Stock
100MG 124 In Stock
200MG 174 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Abacavir sulfate
  • Note
    Research use only, not for human use.
  • Brief Description
    A nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.
  • Description
    A nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.HIV Infection Approved
  • Synonyms
    Abacavir sulfate; Abacavir sulfate salt
  • Pathway
    Microbiology/Virology
  • Target
    HIV
  • Recptor
    HIV-1reverse-transcriptase
  • Research Area
    Infection
  • Indication
    HIV Infection

Chemical Information

  • CAS Number
    188062-50-2
  • Formula Weight
    286.33
  • Molecular Formula
    C14H18N6O
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in H2O
  • SMILES
    C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO.C1CC1NC2=C3C(=NC(=N2)N)N(C=N3)C4CC(C=C4)CO.OS(=O)(=O)O
  • Chemical Name
    2-Cyclopentene-1-methanol, 4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-, (1S,4R)-, sulfate (2:1)

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • BMS-707035

    BMS-707035 is a potent, specific, and reversible HIV-I integrase (IN) inhibitor that blocks HIV IN strand transfer activity with IC50 of 15 nM.

  • YLC2-155

    YLC2-155 is a novel potent HIV-1 reverse transcriptase (RT) inhibitor that inhibits both polymerase (IC50=2.6 uM) and RNase H function (IC50=0.65 uM) of RT.

  • ZBMA-1

    ZBMA-1 is a potent HIV-1 replication inhibitor (IC50=1.01 uM) that efficiently protects APOBEC3G protein by targeting Vif-APOBEC3G complex.